The PI3K/AKT/mTOR signaling pathway is known to facilitate the proliferation of cancer cells, and it has been observed that metformin possesses the ability to impede the activity of this pathway (Ala and Ala, 2021). This evidence concerns the gene AKT1 and cancer.